Navigation Links
Are siRNA Pools Smart?

RT-PCR data were normalized with 18S rRNA real-time RT-PCR.


Comparing siRNA Pools and Single siRNAs: Experimental Design and Results

Quantitative, phenotypic assays were used to determine how well single siRNAs performed relative to siRNA pools. siRNAs targeting 59 kinases, along with positive and negative control siRNAs, were studied. Cell populations were transfected with three single siRNAs (siRNA #1, siRNA #2, or siRNA #3), all targeting the same gene, or a pool of the three siRNAs (siRNA #1 + siRNA #2 + siRNA #3). In the experiments described below, cell number was monitored three days post-transfection (Figure 3), or apoptosis was induced using etoposide one day after transfection, and caspase 3 activity was assayed three days post-transfection (Figure 4). All transfected cells were assayed on the same day using master mixes of dyes and substrates to minimize experimental variability in the studies.


[click here to enlarge]

Figure 3. Cell Proliferation--Single siRNAs vs. siRNA Pools. (A) Expression levels of 59 kinases were reduced in HeLa cells by transfection in 96 well plates of three individual kinase-specific siRNAs or a pool of the three siRNAs. All samples were performed in triplicate. To each well containing siPORT NeoFX Transfection Agent and either one of three siRNAs (30 nM) or the three pooled siRNAs (10 nM each), 8x103 HeLa cells were added in a process termed reverse transfection [2]. Three days post-transfection, the cells were assayed using alamar
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Custom and library siRNA for efficient gene silencing
2. Custom and library siRNA for efficient gene silencing
3. Cancer siRNA Oligo Set Version 1.0
4. Library siRNA
5. Custom siRNA Oligo Synthesis Service
6. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
7. Quantification of siRNA Silencing Efficiency Using the LightCycler System
8. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
9. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection
10. siRNA transfection optimization with the Agilent 2100 bioanalyzer
11. siRNA Design Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Are siRNA Pools Smart

(Date:8/28/2008).... 28 /- Truman Medical Centers (TMC),...ates to install the,Siemens SOMATOM Definition AS ...canner is a highly adaptive scanner, providing exc...sure to the patient., "To be one of the first med..., first of its kind, state-of-the-art technology c...
(Date:8/28/2008)...28 /- Barr Pharmaceuticals,...diary, Barr Laboratories,Inc., received final app...A) to manufacture and market a generic version of ...drobromide), 4 mg, 8 mg and 12 mg tablets. Barr,in...ct immediately., Barr filed an Abbreviated New Dr...
(Date:8/28/2008)...st 28 /- ThromboGenics NV,(...ocused on innovative,treatments for eye disease, v...iness update and its financial results for the six...irst half of 2008, ThromboGenics has achieved a nu...ompany to successfully pursue the,next stage of it...
(Date:8/28/2008)... CoreValve ( www.corevalve.com ) announced today t...uation of its proprietary percutaneous ReValving S...mounted in a self-expanding frame, was initiated l...f. (Business Wire EON) August 28, 2008 -- The fir...ystem were performed in two days by John Ormiston,...
Breaking Biology Technology:Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the World's First Adaptive 128-slice CT Scanner 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5ThromboGenics Announces Half Year Results 2008 2ThromboGenics Announces Half Year Results 2008 3ThromboGenics Announces Half Year Results 2008 4ThromboGenics Announces Half Year Results 2008 5 CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries 2
...Note: "FORWARD VISIONS" Today we begin three week... will appear on the Wisconsin Technology Network (...igned to stimulate awareness, discussion and debat...houghts and technologies surrounding Wisconsin,s H...ember 1-7. WTN will publish EXCLUSIVE articles and...
...tt would like to be sitting in piles of cash right...n manufacturing) isnt, hell take the latest versio... WorkWise , based in Milwaukee, is a provider of e...o maximize profits through improved use of their i...that more than 100 companies upgraded to the lates...
...has been a leader both in cutting-edge health care...ons leading research universities in UW-Madison, a...E Medical Systems, the state is poised to lead aga...though science and engineering have long contribut...s x-rays for diagnosis or radiation for cancer tre...
...Note: The Wisconsin Technology Network has receiv...cs 60-page report titled, the NorthStar Guide t...report contains a primer for Wisconsin companies s... the state. David Ward and his team have agreed to...over the next three weeks the second installment i...
Other Biology Technology:Why Wisconsin Lags Behind the U.S. and Minnesota 2Why Wisconsin Lags Behind the U.S. and Minnesota 3Why Wisconsin Lags Behind the U.S. and Minnesota 4Why Wisconsin Lags Behind the U.S. and Minnesota 5WorkWise Helps Manufacturers Squeeze Bottom Line 2The Role of Engineering in Health Science and Technology 2The Role of Engineering in Health Science and Technology 3Angel Investing in Wisconsin 2Angel Investing in Wisconsin 3Angel Investing in Wisconsin 4Angel Investing in Wisconsin 5
(Date:8/29/2008)...he skin of unwitting caterpillars belongs to one o... researchers report that its diversity is even hig...slide show on the research, please go to: http://...e .) , By combining ecological and genetic data ...he researchers have dramatically increased nearly...
(Date:8/29/2008)...ainly because they lose control of their growth. T...at Ohio State University,s Comprehensive Cancer Ce...rowth in embryos and that contribute to cancer in ...E2f3b are generally believed to work together to ...es from experiments using only cells. Cancer resea...
(Date:8/28/2008)...rst new living species of giant clam in two decade... August 28th in Current Biology , a Cell Press pu...new species, called Tridacna costata , once accou...e Red Sea, it now represents less than one percent...said they cannot say for sure which factors contri...
(Date:8/28/2008)...earch about national, home and business security s... University of Houston professor and his colleague...mmunity when it comes to surveillance. , Two p...fifth annual Institute of Electrical and Electroni...Video and Signal-Based Surveillance (AVSS). It wi...
Breaking Biology News(10 mins):Diversity among parasitic wasps is even greater than suspected 2Diversity among parasitic wasps is even greater than suspected 3Location, location, location important for genes, too 2New giant clam species offers window into human past 2National security remedies among topics at surveillance confab 2National security remedies among topics at surveillance confab 3Chairman and CEO Bill Marriott to Lead Marriott Employees in Torch Relay to Raise 241 25 Million for Childrens Hospitals Nationwide 4503 1Chairman and CEO Bill Marriott to Lead Marriott Employees in Torch Relay to Raise 241 25 Million for Childrens Hospitals Nationwide 4503 2Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension 1471 1Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension 1471 2A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 1A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 2A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 3A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 4A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 5A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 6A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 7A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 8The conservation lens 947 1The conservation lens 947 2The conservation lens 947 3
...esearchers have developed two new technologies for...rst patent-pending technology provides a way for r...aboratory are responding to an anti-cancer drug. T...s at once -- allows for the simultaneous testing o...g on different kinds of cells taken from the body....
...ad view of evolution as a process played out over ...hown that natural selection can turn on a dime -- ...n a study of island lizards exposed to a new preda...ramatically changed direction over a very short ti...ger and then shorter hind legs. , The findings, by...
... a boost tomorrow (14 October) as CSIRO launches i...ysis software at Neuroscience 2006 in Atlanta, Geo...earchers. , HCA-Vision is based on a proprietary m... for automatically tracing and measuring lines in ...xpected, the conference will be an ideal focus for...
...a recurrent cancer of the central nervous system t..., has shown promising results in preliminary data ...ndings from the first group of six patients in the...search Center, showed that vitespen (trademarked a...n tumor, was associated with tumor-specific immune...
Other Biology News:Chemical tests of cell growth enter third dimension 2Chemical tests of cell growth enter third dimension 3Pressured by predators, lizards see rapid shift in natural selection 2Vaccine for brain tumors shows promising results 2Vaccine for brain tumors shows promising results 3
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details.
R26.4C
EnzChek Ultra Xylanase Assay Kit *500 assays*
Anti-Mouse Macrophages (Metallophillic), Purified (Clone MOMA-1) (rat IgG2a)
Biology Products: